This analysis revealed enrichment of BRN2 binding within the first intron of the NFIB gene locus (Fig. 1H), further suggesting that BRN2 may be able to directly bind NFIB and regulate its expression in melanoma cells. The gene discussed is POU3F2; the disease is melanoma.